https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-19 / Cell. Mol. Immunol. 2020 04;17(4):323-334
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-19 / Cell. Mol. Immunol. 2020 04;17(4):323-3342020-03-19 00:00:002020-03-19 00:00:00The function and clinical application of extracellular vesicles in innate immune regulation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-17 / J Adv Res 2020 Jul;24:175-182
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-17 / J Adv Res 2020 Jul;24:175-1822020-03-17 00:00:002023-01-31 16:04:06A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e92020-03-16 00:00:002020-08-26 12:23:32Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Biomedicines 2020 Mar;8(3)2020-03-16 00:00:002021-11-15 19:52:47Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Pharmaceutics 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Pharmaceutics 2020 Mar;12(3)2020-03-12 00:00:002020-08-26 13:44:51Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Front Oncol 2020;10:343
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Front Oncol 2020;10:3432020-03-12 00:00:002020-03-12 00:00:00Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-10 / Front Oncol 2020;10:254
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-10 / Front Oncol 2020;10:2542020-03-10 00:00:002020-08-26 14:24:04Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-06 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-06 / Biomedicines 2020 Mar;8(3)2020-03-06 00:00:002021-11-15 17:52:40New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-06 / Cancers (Basel) 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-06 / Cancers (Basel) 2020 Mar;12(3)2020-03-06 00:00:002020-03-06 00:00:00Combined wIRA-Hyperthermia and Hypofractionated Re-Irradiation in the Treatment of Locally Recurrent Breast Cancer: Evaluation of Therapeutic Outcome Based on a Novel Size Classification
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-05 / Cancers (Basel) 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-05 / Cancers (Basel) 2020 Mar;12(3)2020-03-05 00:00:002020-08-26 13:47:31Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting